Please assess the completion status of the following clinical trial:

Trial Title: Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with uncomplicated malaria will be enrolled in cohort 1~* Pediatric patients with uncomplicated malaria will be enrolled in cohort 2~* Pediatric patients with severe malaria will be enrolled in cohort 3~* Plasmodium falciparum malaria confirmed in blood smear~* Fever within the last 24 hours.~Exclusion Criteria:~* Treatment with an antimalarial agent within 72h of screening~* Severe concomitant disease~* Pregnant or breast-feeding women~* Women of child bearing potential not protected by an effective method of birth control~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: EXPERIMENTAL): Adult patients with uncomplicated malaria
- Cohort 2 (Type: EXPERIMENTAL): Pediatric patients with uncomplicated malaria
- Cohort 3 (Type: EXPERIMENTAL): Pediatric patients with severe malaria

Based on this trial design, predict the completion outcome and termination type (if applicable).